Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: A meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Xiong, Qi ^a   Li, Zhiliang ^b   Li, Zhaohui ^a   Zhu, Yi ^a   Abdulhalim, Sancar ^a   Wang, Ping ^a   Cai, Xiaojun ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; MITOMYCIN; RANIBIZUMAB;

ANTERIOR EYE CHAMBER; ARTICLE; BLEB LEAKAGE; CHOROIDAL EFFUSION; DRUG EFFICACY; DRUG TOLERABILITY; EYE DISEASE; GLAUCOMA; HUMAN; INCIDENCE; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; META ANALYSIS; SYSTEMATIC REVIEW; TRABECULECTOMY;

AGED; ANTIMETABOLITES; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; ODDS RATIO; SOFTWARE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84895539623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088403     Document Type: Article

References (39)

1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262-267.
2. Burr J, Azuara-Blanco A, Avenell A, Tuulonen A (2012) Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 9:CD004399.
3. Hitchings R (1998) Initial Treatment for Open-Angle Glaucoma-Medical, Laser, or Surgical?: Surgery Is the Treatment of Choice for Open-Angle Glaucoma. Archives of Ophthalmology 116:241.
4. Cairns J (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673-679.
5. Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149-170. (Pubitemid 18008538)
6. Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48:314-346. (Pubitemid 36549254)
7. Addicks EM, Quigley HA, Green WR, Robin AL (1983) Histologic characteristics of filtering blebs in glaucomatous eyes. Archives of Ophthalmology 101:795-798. (Pubitemid 13133119)
8. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, et al. (1996) Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 114:943-949. (Pubitemid 26271459)
9. Seah SK, Prata JA Jr, Minckler DS, Baerveldt G, Lee PP, et al. (1995) Hypotony following trabeculectomy. J Glaucoma 4:73-79.
10. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, et al. (2009) The role of vascular endothelial growth factor in wound healing. J Surg Res 153:347-358.
11. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, et al. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152:1445-1452. (Pubitemid 28275003)
12. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, et al. (2009) Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci 50:5217-5225.
13. Grewal DS, Jain R, Kumar H, Grewal SPS (2008) Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy: a pilot study. Ophthalmology 115:2141-2145. e2142.
14. Jonas JB, Spandau UH, Schlichtenbrede F (2007) Intravitreal bevacizumab for filtering surgery. Ophthalmic Research 39:121-122. (Pubitemid 46909871)
15. Higgins JP, Green S, Collaboration C (2008) Cochrane handbook for systematic reviews of interventions. Wiley Online Library 5.
16. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151:264-269.
17. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health 52:377-384. (Pubitemid 28438523)
18. Reck M, Von Pawel J, Zatloukal PV, Ramlau R, Gorbounova V, et al. (2010) Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Annals of oncology 21:1804-1809.
19. Jurkowska-Dudzinska J, Kosior-Jarecka E, Zarnowski T (2012) Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year. Clin Experiment Ophthalmol 40:e135-142.
20. Nilforushan N, Yadgari M, Kish SK, Nassiri N (2012) Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 153:352-357 e351.
21. Sengupta S, Venkatesh R, Ravindran RD (2012) Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. J Glaucoma 21:450-459.
22. Simsek T, Cankaya AB, Elgin U (2012) Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs. J Ocul Pharmacol Ther 28: 542-546.
23. Akkan JU, Cilsim S (2013) Role of Subconjunctival Bevacizumab as an Adjuvant to Primary Trabeculectomy: A Prospective Randomized Comparative 1-Year Follow-up Study. J Glaucoma 00:000-000.
24. Kahook MY (2010) Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 150:399-403 e391.
25. Chua BE, Nguyen DQ, Qin Q, Ruddle JB, Wells AP, et al. (2012) Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Experiment Ophthalmol 40:773-779.
26. Suh W, Kee C (2013) The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil. J Ocul Pharmacol Ther 29:646-651.
27. Freiberg FJ, Matlach J, Grehn F, Karl S, Klink T (2013) Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy. Clin Ophthalmol 7:1211-1217.
28. Hitchings RA, Grierson I (1983) Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K 103:84-88. (Pubitemid 14233800)
29. Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, et al. (2013) Efficacy and Safety of Trabeculectomy vs Nonpenetrating Surgical Procedures: A Systematic Review and Meta-analysis. JAMA Ophthalmol 131:1573-1582.
30. Parrish R, Minckler D (1996) "Late endophthalmitis" - filtering surgery time bomb? Ophthalmology 103:1167-1168.
31. Pakravan M, Miraftabi A, Yazdani S, Koohestani N, Yaseri M (2011) Topical mitomycin-C versus subconjunctival 5-fluorouracil for management of bleb failure. Journal of ophthalmic & vision research 6:78-86.
32. Khaw P, Grehn F, Holló G, Overton B, Wilson R, et al. (2007) CAT-152 0102 Trabeculectomy Study Group et al. A phase III study of subconjunctival human anti-transforming growth factor beta (2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114:1822-1830.
33. Heatley G, Kiland J, Faha B, Seeman J, Schlamp CL, et al. (2004) Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. Gene therapy 11:949-955. (Pubitemid 38923618)
34. Wang X, Crowston JG, White AJ, Zoellner H, Healey PR (2013) Interferon-alpha and Interferon-gamma modulate Fas-mediated apoptosis in Mitomycin-C resistant Human Tenon's Fibroblasts. Clin Experiment Ophthalmol 14: 000-000.
35. Nakamura-Shibasaki M, Ko J, Takenaka J, Chikama TI, Sonoda KH, et al. (2013) Matrix metalloproteinase and cytokine expression in Tenon fibroblasts during scar formation after glaucoma filtration or implant surgery in rats. Cell biochemistry and function 31:482-488.
36. Choritz L, Grub J, Wegner M, Pfeiffer N, Thieme H (2010) Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts - potential use in drug-eluting glaucoma drainage devices. Graefes Arch Clin Exp Ophthalmol 248:197-206.
37. Kahook MY, Schuman JS, Noecker RJ (2005) Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic surgery, lasers & imaging: the official journal of the International Society for Imaging in the Eye 37:148-150.
38. Coote MA, Ruddle JB, Qin Q, Crowston JG (2008) Vascular changes after intra-bleb injection of bevacizumab. J Glaucoma 17:517-518.
39. Yu J, Kahook M, Schuman J (2007) Bevacizumab binding to human sclera post topical application [E-Abstract 4815]. Invest Ophthalmol Vis Sci 48:4815.